Press Release

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 16, 2014--
Covidien
plc (NYSE: COV) today announced that its Board of Directors has
declared a quarterly cash dividend of $0.32 per ordinary share. The
dividend is payable on February 20, 2014, to shareholders of record on
January 28, 2014.

About Covidien

Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien develops,
manufactures and sells a diverse range of industry-leading medical
device and supply products. With 2013 revenue of $10.2 billion, Covidien
has more than 38,000 employees worldwide in more than 70 countries, and
its products are sold in over 150 countries. Please visit www.covidien.com
to learn more about our business.